Detalles de la búsqueda
1.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Lancet
; 387(10020): 770-8, 2016 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26673811
2.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet Oncol
; 17(2): 200-211, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26655421
3.
Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study.
Med Oncol
; 35(11): 141, 2018 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187210
Resultados
1 -
3
de 3
1
Próxima >
>>